Dave S.B. Hoon, Professor and Director of Dept. of Translational Molecular Medicine at the Saint John’s Cancer Institute, interacts with external academic, industry, government agencies, and international cancer centers to develop innovative translational cancer research opportunities. He has over 30 patents on his studies and has co-authored over 350 peer-reviewed articles and reviews, primarily related to translational molecular oncology of human solid tumors. He is the original pioneer of JWCI in Santa Monica, 1991.
Dr. Hoon pioneered investigations of CTC and circulating cell-free DNA/miRNA biomarkers for monitoring cancer in patients enrolled in phase II/III clinical trials. Since early 1990’s Dr. Hoon’s team has developed molecular biomarkers for molecular staging of sentinel lymph nodes and classification of human solid tumors including CRC, melanoma and breast cancer. In the last decade he and his team have developed programs for assessment of epigenetic and ubiquitin regulatory pathways of solid tumors such as melanoma, breast cancer, gastrointestinal cancers, and brain tumors. Dr. Hoon has trained over 70 MD/PhD fellows and over a dozen graduate students. The department consists of >20 employees. Awarded multiple NCI RO1s and PO1s, and DOD grants in the past 30 yrs.
Education and Training
Bachelor of Science University of Victoria
Master of Science University of Manitoba
Doctoral Degree University of Saskatchewan
Fellowship UCLA Surgical Oncology
Program Project Management Certification California Technology Institute
Honors and Awards
Boerhaave Honorary Professorship and Medal (Surgery Oncology) at Leiden University Medical Center (LUMC), Netherlands, 2010.
Professional Memberships
American Association Clinical Oncology, American Association Clinical Chemistry, American Association of Cancer Research, , Society of Melanoma Research, U. of Victoria alumni, U. of Manitoba alumni, U. of Saskatchewan alumni, U. of California, Los Angeles Medical alumni
Board Member: International Society of Sentinel Node 2000-2018
California Breast Cancer Research Board 2015- present